ArticleFrontiers in bioengineering and biotechnology2026
Quantitative determination of mercury in blood-based DL-cysteine-modified direct mercury analyzer method.
Article in Frontiers in bioengineering and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Occupational mercury poisoning is a significant work-related illness due to that mercury vapor and its compounds can enter the human body and cause systemic damage. Therefore, regular blood mercury monitoring is essential for occupationally exposed individuals. Among existing detection methods, mercury analyzers are widely used for direct blood mercury determination. Despite the utility of direct mercury analyser (DMA), their application to blood samples is often compromised by limitations such as method instability and mercury carryover. To address these challenges, this study introduces a DL-cysteine-assisted determination method. It is based on the principle that DL-cysteine forms stable complexes with mercury in blood, thereby mitigating container adsorption and memory effects. Specifically, DL-cysteine solution was incorporated into both the mercury calibration standards and the blood samples within the sample boat prior to analysis using a DMA. The limit of detection was 0.5 μg/L, and the limit of quantification was 1.5 μg/L. Method accuracy, evaluated by spiked recovery, ranged from 99.14% to 99.92%. Experiments demonstrated that the stability, recovery, and repeatability of the direct mercury determination method were improved by introducing DL-cysteine, which offers practical value in enhancing the performance of direct mercury determination methods and is suitable for routine blood mercury monitoring.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.